HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,873-1,884 of 7,264
Device study icon
CompletedNCT03378570

rTMS for MDD: 5.5cm Rule vs. F3 Targeting

Official study title

The Effects of Repetitive Transcranial Magnetic Stimulation Prefrontal Target Location on Outcomes for Major Depressive Disorder

This study has finished and is no longer accepting participants.

In Iowa City
DepressionDevice studyAges 18–90
Countries
United States
Sponsor
Nicholas Trapp
Device study icon
UnknownNCT06028984

Self-guided Treatment for Depression

Official study title

Self-guided Treatment for Adolescents/Adults Navigating Depression (STAND-MDD): A Randomized Controlled Trial

Current recruitment status is unconfirmed.

In San Francisco
DepressionDevice studyAges 13+
Countries
United States
Sponsor
Big Health Inc.
Other study type icon
WithdrawnNCT06328140

Sleep Quality, Cognitive Performance, and Computerized Cognitive Training

Official study title

Sleep Quality, Cognitive Performance, and Computerized Cognitive Training Comparison of Patients Treated With Lurasidone vs.Patients With Major Depression Receiving Selective Serotonin Reuptake Inhibitor(SSRI) Treatment as Usual

This study was withdrawn before enrollment.

In Atlanta
Depression, Bipolarity, ...Observational studyAges 18–65
Countries
United States
Sponsor
George West Mental Health Foundation d/b/a Skyland Trail
Drug study icon
CompletedNCT06126497

Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients

What is this study about?

Researchers studied Ropanicant, tracking side effects to assess safety in people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Bellflower
DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Suven Life Sciences Limited
Drug study icon
CompletedNCT05203341

NBI-1065845 for depression

What is this study about?

Researchers compared NBI-1065845 and placebo to find out how the approaches affected depression symptoms in adults with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
DepressionMedication studyAges 18–65
Countries
United States, Bulgaria, Czechia, + 3 others
Sponsor
Neurocrine Biosciences (Biotech company)
Other study type icon
Enrolling By InvitationNCT06582147

The Social Determinants of Health Screening and Referral Project

Official study title

Implementing a Social Determinants of Health Screening and Referral Care Model in the Neonatal Intensive Care Unit

This study is by invitation only.

Multiple locations, including Denver
DepressionInterventional studyAges 18+
Countries
United States
Sponsor
University of Massachusetts, Worcester
Behavioral study icon
Enrolling By InvitationNCT07264621

The University of Oregon ACCESS Project

Official study title

Adaptive Multi-tiered School-based Prevention to Promote Youth Mental Health and Create Equitable and Sustainable Systems of Care

This study is by invitation only.

Multiple locations, including Cottage Grove
DepressionBehavioural studyAges 11+
Countries
United States
Sponsor
University of Oregon
Other study type icon
UnknownNCT05585047

Treatment Response Biomarkers in MDD

Official study title

Prospective Biomarkers for Treatment Response in Major Depressive Disorder

Current recruitment status is unconfirmed.

In Changsha
DepressionObservational studyAges 18–60
Countries
China
Sponsor
Zhang Yan
Drug study icon
CompletedNCT06309472

study of Mirtazapine for Depression in IBD

Official study title

A Multi-centre, Double-blind Randomised Controlled Trial to Compare Mirtazapine Versus Placebo Over 12 Weeks in Patients With Multimorbid Major Depression and Inflammatory Bowel Disease (MD-IBD): a Feasibility Study

This study has finished and is no longer accepting participants.

In London
DepressionMedication studyAges 18–125
Countries
United Kingdom
Sponsor
King's College London (University)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.